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The authors conclude that the low cost and 
improvement in QOL support the continued use of 
PTA in claudication. As only 26-40% of claudicants 
have lesions amenable to angioplasty, 3'4 the overall 
benefit on QOL in the patient group as a whole is 
decreased. In contrast, supervised exercise training 
programmes are applicable to all claudicants and are 
known to increase walking distance. 5 The beneficial 
effect of supervised exercise on QOL has not been 
reported. Some degree of exercise supervision is 
essential to provide encouragement and ensure com- 
pliance as unsupervised exercise has been reported to 
effect a minimal improvement in quality of life. 6 
P. V. Tisi and C. P. Shearman 
Southampton, U.K. 
Quality of Life Following Percutaneous 
Transluminal Angioplasty for Claudication 
Sir, 
The recent paper by Cook et al) showed that patients 
undergoing percutaneous transluminal angioplasty 
(PTA) have lower baseline quality of life (QOL) scores 
compared to a normal population and that revascular- 
isation improved QOL and walking distance score. We 
would like to make several points regarding this 
study. The authors have presumably used published 
figures for baseline EuroQOL scores in a normal 
population rather than comparing the 29 patients to an 
age and sex-matched control group, which would be 
more relevant Lower baseline QOL in claudicants 
compared to controls has recently been reported using 
the Nottingham Health Profile questionnaire. 2 
The EuroQOL questionnaire was completed on the 
ward prior to PTA and it is likely that the stress of 
admission to hospital would adversely affect the 
response to QOL parameters. It is possible that 
patients may also underestimate their subjective walk- 
ing distance score in order to ensure that the proce- 
dure is not cancelled due to spontaneous improve- 
ment in symptoms. Perhaps an objective treadmill 
assessment before and after PTA would more accu- 
rately reflect he correlation between improved walk- 
ing distance and QOL? The authors have failed to 
include the two patients with failed PTA in their 
analysis, although we accept hat surgery itself may 
improve QOL. A long-term assessment of the effect of 
PTA on QOL is needed as restenosis after the 6 week 
follow-up may significantly reduce the improvement 
compared to baseline levels, and may possibly lead to 
a deterioration. 
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Cranial Nerve Injuries and Carotid 
Endarterectomy 
Sir, 
Cranial nerve injuries following operations on the 
carotid bifurcation is an easily identifiable problem for 
patients but not for surgeons, at least not for all of 
them. In most reported series of carotid surgery, 
cranial nerve injuries (CNI) are infrequently men- 
tioned, and some authors have expressed the opinion 
that such injuries, should be reported only if they are 
permanent. 
In the November issue of the Journal, ~ D. Bergqvist 
and his co-workers reported the results of a very 
thorough prospective study, using the resources of the 
department of speech therapy on 689 carotid endarter- 
ectomies. As was expected, the incidence of cranial 
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nerve injuries was 12.5%. In 1981 we performed the 
same study with a speech therapist. 2'3 This study had 
almost identical results to the present Swedish study 
with a slightly higher incidence of CNI mainly 
because we included injuries to the mandibular 
branch of the facial N. and the Greater Auricular N. 
Cranial nerve injuries, it seems, are here to stay 
following carotid surgery, despite the refinements in 
the technique. The fact that most of them are tempo- 
rary in nature and resolve within 60 days, does not 
mean that they should not be included in perioper- 
ative morbidity rates which should include all events 
within the 30 days period following surgery. 4 Fur, 
thermore, in deciding the real value of endovascular 
alternatives, we should include the issue of nerve 
injuries that D. Bergqvist brought back to our 
attention. 
C. Liapis 
Athens, Greece 
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Quality of Life in Patients with Intermittent 
Claudication 
Sir, 
We read with interest he paper by Khaira et al. 1 but 
question the validity of the method and conclusions. 
The choice of the age/sex matched controls in this 
study may have led to false results: Claudicants are 
well known to have a higher prevalence of cardio- and 
23 cerebrovascular disease ' whereas a surgical waiting 
list for minor procedures (as was used to supply the 
control group) has a large proportion of patients in 
good general health. It is not surprising therefore that 
the claudicant group had an overall worse quality of 
life than the control and although excluding patients 
with "other ailments" increased the significance in the 
difference between the two groups there is no indica- 
tion what these ailments were. 
The authors state that "restriction in mobility" was 
the underlying cause of the difference between claudi- 
cants and controls. It cannot however, be assumed that 
the restriction in mobility was due to claudication and 
not, for example, stroke or ischaemic heart disease. 
We agree wholeheartedly with the call for pro- 
spective controlled trials comparing quality of life 
measurement with traditional efficacy/safety parame- 
ters: Generic quality of life instruments are useful as 
outcome measure if used for pre- and postoperative 
comparisons. It must be remembered however that a 
generic instrument (such as the Nottingham Health 
profile) can only assess quality of life per se, not the 
impact of claudication on quality of life, because 
generic instruments do not differentiate between the 
relative effects of claudication and the coexistent 
disorders which are so frequent in these patients. If 
clinicians truly wish to measure the impact of inter- 
mittent claudication on quality of life and use this 
measurement to influence the management of their 
patients it is essential that a disease-specific instru- 
ment is used otherwise the quality of life may be 
underestimated and the need for intervention overes- 
timated. 
G. Hicken and M. Ameli 
Toronto, Canada 
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Author's Reply 
Sir, 
We thank Messrs Hicken and Amali for their interest 
in our paper. Our aim was to select a control 
population which had undergone the same pattern of 
referral (i.e. from GP to hospital specialist) as the 
patients with intermittent claudication. Previous pub- 
lications on this subject had used inappropriate 
controls. In our questionnaire we enquired about 
problems such as angina, shortness of breath on 
exertion, stroke, previous heart attacks, and arthritis 
(i.e. conditions that would limit mobility). We found 
that the two groups were well matched for these 
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